Authors:
Moukha-Chafiq, O
Taha, ML
Lazrek, HB
Pannecouque, C
Witvrouw, M
De Clercq, E
Barascut, JL
Imbach, JL
Citation: O. Moukha-chafiq et al., Synthesis and biological activity of 4-substituted 1-[1-(2-hydroxyethoxy)methyl-1,2,3-triazol-(4&5)-ylmethyl]-1H-pyrazolo[3,4-d]pyrimidines, NUCLEOS NUC, 20(10-11), 2001, pp. 1797-1810
Authors:
Moukha-Chafiq, O
Taha, ML
Lazrek, HB
Vasseur, JJ
Pannecouque, C
Witvrouw, M
De Clercq, E
Citation: O. Moukha-chafiq et al., Synthesis and biological evaluation of some 4-substituted 1-[1-(4-hydroxybutyl)-1,2,3-triazol-(4&5)-ylmethyl]1H-pyrazolo-[3,4-d]pyrimidines, NUCLEOS NUC, 20(10-11), 2001, pp. 1811-1821
Authors:
Casimiro-Garcia, A
De Clercq, E
Pannecouque, C
Witvrouw, M
Loftus, TL
Turpin, JA
Buckheit, RW
Fanwick, PE
Cushman, M
Citation: A. Casimiro-garcia et al., Synthesis and anti-HIV activity of cosalane analogues incorporating two dichlorodisalicylmethane pharmacophore fragments, BIO MED CH, 9(11), 2001, pp. 2827-2841
Authors:
Asres, K
Bucar, F
Kartnig, T
Witvrouw, M
Pannecouque, C
De Clercq, E
Citation: K. Asres et al., Antiviral activity against human immunodeficiency virus type 1 (HIV-1) andtype 2 (HIV-2) of ethnobotanically selected ethiopian medicinal plants, PHYTOTHER R, 15(1), 2001, pp. 62-69
Authors:
Selvam, P
Chandramohan, M
De Clercq, E
Witvrouw, M
Pannecouque, C
Citation: P. Selvam et al., Synthesis and anti-HIV activity of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene) amino]-N(4,6-dimethyl-2-pyrimidinyl)-benzene sulfonamide and its derivatives, EUR J PH SC, 14(4), 2001, pp. 313-316
Authors:
Chaouni-Benabdallah, A
Galtier, C
Allouchi, H
Kherbeche, A
Debouzy, JC
Teulade, JC
Chavignon, O
Witvrouw, M
Pannecouque, C
Balzarini, J
de Clercq, E
Enguehard, C
Gueiffier, A
Citation: A. Chaouni-benabdallah et al., Synthesis of 3-nitrosoimidazo[1,2-a]pyridine derivatives as potential antiretroviral agents, ARCH PHARM, 334(7), 2001, pp. 224-228
Authors:
Van Laethem, K
Witvrouw, M
Pannecouque, C
Van Remoortel, B
Schmit, JC
Esnouf, R
Kleim, JP
Balzarini, J
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype, AIDS, 15(5), 2001, pp. 553-561
Authors:
Goebel, FD
Hemmer, R
Schmit, JC
Bogner, JR
de Clercq, E
Witvrouw, M
Pannecouque, C
Valeyev, R
Vandevelde, M
Margery, H
Tassignon, JP
Citation: Fd. Goebel et al., Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapy, AIDS, 15(1), 2001, pp. 33-45
Authors:
Pluymers, W
Neamati, N
Pannecouque, C
Fikkert, V
Marchand, C
Burke, TR
Pommier, Y
Schols, D
De Clercq, E
Debyser, Z
Witvrouw, M
Citation: W. Pluymers et al., Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters (vol 58, pg 641, 2000), MOLEC PHARM, 59(2), 2001, pp. 403-403
Authors:
Santhosh, KC
Paul, GC
De Clercq, E
Pannecouque, C
Witvrouw, M
Loftus, TL
Turpin, JA
Buckheit, RW
Cushman, M
Citation: Kc. Santhosh et al., Correlation of anti-HIV activity with anion spacing in a series of cosalane analogues with extended polycarboxylate pharmacophores, J MED CHEM, 44(5), 2001, pp. 703-714
Authors:
Vlieghe, P
Bihel, F
Clerc, T
Pannecouque, C
Witvrouw, M
De Clercq, E
Salles, JP
Chermann, JC
Kraus, JL
Citation: P. Vlieghe et al., New 3 '-azido-3 '-deoxythymidin-5 '-yl O-(omega-hydroxyalkyl) carbonate prodrugs: Synthesis and anti-HIV evaluation, J MED CHEM, 44(5), 2001, pp. 777-786
Authors:
Vlieghe, P
Clerc, T
Pannecouque, C
Witvrouw, M
De Clercq, E
Salles, JP
Kraus, JL
Citation: P. Vlieghe et al., New 3 '-azido-3 '-deoxythymidin-5 '-yl O-(4-hydroxyalkyl or -alkenyl or -alkylepoxide) carbonate prodrugs: Synthesis and anti-HIV evaluation, J MED CHEM, 44(18), 2001, pp. 3014-3021
Authors:
Heinisch, G
Matuszczak, B
Spielmann, E
Witvrouw, M
Pannecouque, C
De Clercq, E
Citation: G. Heinisch et al., Pyridazines 92. Synthesis of dialkyldipyridazinodiazepinones as potential HIV-1 reverse transcriptase inhibitors, J HETERO CH, 38(1), 2001, pp. 125-130
Authors:
Chaouni-Benabdallah, A
Galtier, C
Allouchi, H
Kherbeche, A
Chavignon, O
Teulade, JC
Witvrouw, M
Pannecouque, C
Snoeck, R
Andrei, G
Balzarini, J
De Clercq, E
Fauvelle, F
Enguehard, C
Gueiffier, A
Citation: A. Chaouni-benabdallah et al., 3-benzamido, ureido and thioureidoimidazo[1,2-a]pyridine derivatives as potential antiviral agents, CHEM PHARM, 49(12), 2001, pp. 1631-1635
Authors:
Varvaresou, A
Iakovou, K
Filippatos, E
Souli, C
Calogeropoulou, T
Ioannidou, I
Kourounakis, AP
Pannecouque, C
Witvrouw, M
Padalko, E
Neyts, J
De Clercq, E
Tsotinis, A
Citation: A. Varvaresou et al., Synthesis, antiretroviral and antioxidant evaluation of a series of new benzo[b]furan derivatives, ARZNEI-FOR, 51(2), 2001, pp. 156-162
Authors:
Casimiro-Garcia, A
De Clercq, E
Pannecouque, C
Witvrouw, M
Stup, TL
Turpin, JA
Buckheit, RW
Cushman, M
Citation: A. Casimiro-garcia et al., Synthesis and anti-HIV activity of cosalane analogues incorporating nitrogen in the linker chain, BIO MED CH, 8(1), 2000, pp. 191-200
Authors:
Paul, GC
De Clercq, E
Pannecouque, C
Witvrouw, M
Loftus, TL
Turpin, JA
Buckheit, RW
Cushman, M
Citation: Gc. Paul et al., Identification of optimal anion spacing for anti-HIV activity in a series of cosalane tetracarboxylates, BIOORG MED, 10(18), 2000, pp. 2149-2152
Authors:
Peloponese, JM
Gregoire, C
Opi, S
Esquieu, D
Sturgis, J
Lebrun, E
Meurs, E
Collette, Y
Olive, D
Aubertin, AM
Witvrow, M
Pannecouque, C
De Clercq, E
Bailly, C
Lebreton, J
Loret, EP
Citation: Jm. Peloponese et al., H-1-C-13 nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein, CR AC S III, 323(10), 2000, pp. 883-894
Authors:
Van Vaerenbergh, K
Van Laethem, K
Albert, J
Boucher, CAB
Clotet, B
Floridia, M
Gerstoft, J
Hejdeman, B
Nielsen, C
Pannecouque, C
Perrin, L
Pirillo, MF
Ruiz, L
Schmit, JC
Schneider, F
Schoolmeester, A
Schuurman, R
Stellbrink, HJ
Stuyver, L
Van Lunzen, J
Van Remoortel, B
Van Wijngaerden, E
Vella, S
Witvrouw, M
Yerly, S
De Clercq, E
Desmyter, J
Vandamme, AM
Citation: K. Van Vaerenbergh et al., Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues, ANTIM AG CH, 44(8), 2000, pp. 2109-2117
Authors:
Witvrouw, M
Fikkert, V
Pluymers, W
Matthews, B
Mardel, K
Schols, D
Raff, J
Debyser, Z
De Clercq, E
Holan, G
Pannecouque, C
Citation: M. Witvrouw et al., Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (Reverse transcriptase/integrase) in the virus replicative cycle, MOLEC PHARM, 58(5), 2000, pp. 1100-1108
Authors:
Pluymers, W
Neamati, N
Pannecouque, C
Fikkert, V
Marchand, C
Burke, TR
Pommier, Y
Schols, D
De Clercq, E
Debyser, Z
Witvrouw, M
Citation: W. Pluymers et al., Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters, MOLEC PHARM, 58(3), 2000, pp. 641-648